High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells

Human Gene Therapy

Volumn 10, Issue 7, 1999, Pages 1163-1173

  Marx, Jeffrey C ^a   Allay, James A ^a   Persons, Derek A ^a   Nooner, Sharon A ^a   Hargrove, Phillip W ^a   Kelly, Patrick F ^a   Vanin, Elio F ^a   Horwitz, Edwin M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PROPIDIUM IODIDE; VIRUS RECEPTOR; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; FLUORESCENCE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STROMA CELL; TRANSGENE;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICE; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; STROMAL CELLS; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 0033135776     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018157     Document Type: Article

References (48)

1. ALLAY, J.A., DENNIS, J.E., HAYNESWORTH, S.E., MAJUMDAR, M.K., CLAPP, D.W., SHULTZ, L.D., CAPLAN, A.I., and GERSON, S.L. (1997a). LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum. Gene Ther. 8, 1417-1427.
2. ALLAY, J.A., SPENCER, H.T., WILKINSON, S.L., BELT, J.A., BLAKLEY, R.L., and SORRENTINO, B.P. (1997b). Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood 90, 3546-3554.
3. BODINE, D.M., TRAILSMITH, M., and KOMM, B.S. (1996). Development and characterization of a conditionally transformed adult human osteoblastic cell line. J. Bone Min. Res. 11, 806-819.
4. BOLOTIN, E., NOLTA, J., SMITH, S., DAO, M., and WEINBERG, K. (1996). Gene therapy with marrow stroma transduced with IL-7 gene rapidly after murine bone marrow transplant. Blood 88, 135a.
5. BRENNER, M.K., HESLOP, H.E., RILL, D., LI, C., NILSON, T., ROBERTS, M., SMITH, C., KRANCE, R., and ROONEY, C. (1994). Gene transfer and bone marrow transplantation. Cold Spring Harbor Symp. Quant. Biol. LIX, 691-697.
6. BUNNELL, B.A., MUUL, L.M., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
7. CHALLITA, P.M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic cells is associated with methylation. Proc. Natl. Acad. Sci. U.S.A. 91, 2567-2571.
8. CHERINGTON, V., CHIANG, G.G., McGRATH, C.A., GAFFNEY, A., GALANOPOULOS, T., MERRILL, W., BIZINKAUSKAS, C.B., HANSEN, M., SOBOLEWSKI, J., LEVINE, P.H., GREENBERGER, J.S., and HURWITZ, D.R. (1998). Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to plasma of dogs after reinfusion. Hum. Gene Ther. 9, 1397-1407.
9. CHIEN, M.L., FOSTER, J.L., DOUGLAS, J.L., and GARCIA, J.V. (1997). The amphotropic murine leukemia virus receptor gene encodes a 71-kilodalton protein that is induced by phosphate depletion. J. Virol. 71, 4564-4570.
10. CHIEN, M.-L., O'NEILL, E., and GARCIA, J.V. (1998). Phosphate depletion enhancers the stability of the amphotropic murine leukemia virus receptor mRNA. Virology 240, 109-117.
11. CHUAH, M.K.L., BREMS, H., VANSLEMBROUCK, V., COLLEN, D., and VANDENDRIESSCHE, T. (1998). Bone marrow stromal cells as targets for gene therapy of hemophilia A. Hum. Gene Ther. 9, 353-365.
12. CHUCK, A.S., and PALSSON, B.O. (1996). Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. Hum. Gene Ther. 7, 743-750.
13. DAO., M.A., HANNUM, C.H., KOHN, D.B., and NOLTA, J.A. (1997). FLT3 ligand preserves the ability to human CD34+ progenitors to sustain long-term hematopoiesis in immuno-deficient mice after ex vivo retroviral-mediated transduction. Blood 89, 446-456.
14. DING., L.M., SAYLORS, R., and MUNSHI, N.C. (1995). The stromal cell as a vehicle for ex vivo gene transfer. Blood 86(Suppl. 1), 409a.
15. DUNBAR, C.E., SEIDEL, N.E., DOREN, S., SELLERS, N.E., CLINE, A.P., METZGER, M.E., AGRICOLA, B.A., DONAHUE, R.E., and BODINE, D.M. (1996). Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cell primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 93, 11871-11876.
16. FERRARI, G., CUSELLA-DE ANGELIS, G., COLETTA, M., PAOLUCCI, E., STORNAIUOLO, A., COSSU, G., and MAVILIO, F. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530.
17. GRAUBERT, T.A., HUG, B.A., WESSELSCHMIDT, R., HSIEH, C.-L., RYAN, T.M., TOWNES, T.M., and LEY, T.J. (1998). Stochastic, stage-specific mechanisms account for the variegation of a human globin transgene. Nucleic Acids Res. 26, 2849-2858.
18. HANAZONO, Y., YU, J.M., DUNBAR, C.E., and EMMONS, R.V. (1997). Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disadvantage. Hum. Gene Ther. 8, 1313-1319.
19. HOEBEN, R.C., FALLAUX, F.J., VAN TILBURG, N.H., CRAMER, S.J., VAN ORMONDT, H., BRIET, E., and VAN DER EB, A.J. (1993). Toward gene therapy for hemphilia A: Long-term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice. Hum. Gene Ther. 4, 179-186.
20. HORWITZ, E.M., PROCKOP, D.J., MARINI, J.C., FITZPATRICK, L.A., GORDON, P., KOO, W., NEEL, M., ORCHARD, P., and BRENNER, M.K. (1997). Bone marrow transplantation (BMT) to correct the mesenchymal defect of children with osteogenesis imperfecta. Blood 90, 230a.
21. HUANG, Z.-M., and BENEDICT YEN, T.S. (1995). Role of the hepatitis B virus post-transcriptional regulatory element in export of intronless transcripts. Mol. Cell. Biol. 15, 3864-3869.
22. HURWITZ, D.R., KIRCHGESSER, M., MERRILL, W., GALANOPOULOS, T., McGRATH, C.A., EMAMI, S., HANSEN, M., CHERINGTON, V., APPEL, J.M., BIZINKAUSKAS, C.B., BRACKMANN, H.H., LEVINE, P.H., and GREENBERGER, J.S. (1997). Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum. Gene Ther. 8, 137-156.
23. HURWITZ, D.R., CHERINGTON, V., RUBIN, H., WANG, T., SOBOLEWSKI, J., GALANOPOULOS, T., NATALE, A., McGRATH, C.A., LEVINE, P.H., GREENBERGER, J.S., and CHAING, G.G. (1998). Ex vivo gene therapy of hemophilia A and B using bone marrow stromal cells in canine model. Am. Soc. Gene Ther. 93a.
24. KADAN, M.J., STURM, S., ANDERSON, W.F., and EGLITIS, M.A. (1992). Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66, 2281-2287.
25. KAVANAUGH, M.P., MILLER, D.G., ZHANG, W., LAW, W., KOZAK, S.L., KABAT, D., and MILLER, A.D. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. U.S.A. 91, 7071-7075.
26. KEATING, A., HORSFALL, W., HAWLEY, R.G., and TONEGUZZO, F. (1990). Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. Exp. Hematol. 18, 99-102.
27. KOHN, D.B., WEINBERG, K.I., NOLTA, J.A., HEISS, L.N., LENARSKY, C. CROOKS, G.M., HANLEY, M.E., ANNETT, G., BROOKS, J.S., EL-KHOUREIY, A., LAWRENCE, K., WELLS, S., MOEN, R.C., BASTIAN, J., WILLIAMS-HERMAN, D.E., ELDER, M., WARA, D., BOWEN, T., HERSHFIELD, M.S., MULLEN, C.A., BLAESE, R.M., and PARKMAN, R. (1995). Engraftment of gene-modified umbilical cord blood in neonates with adenosine deaminase deficiency. Nature Med. 1, 1017-1023.
28. KRALL, W.J., SKELTON, D.C., YU, X.-J., RIVIERE, I., LEHN, P., MULLIGAN, R.C., and KOHN, D.B. (1996). Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther. 3, 37-48.
29. KRISHAN, A. (1975). Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66, 188-193.
30. LAM, J.S., REEVES, M.E., COWHERD, R., ROSENBERG, S.A., and HWU, P. (1996). Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum. Gene Ther. 7, 1415-1422.
31. MAJUMDAR, M.K., JAISWAL, N., MACKAY, A.M., PITTENGER, M.F., BRUDER, S.P., and MOSCA, J.D. (1998). High efficiency gene transfer into mesenchymal stem cells (MSCs) and maintenance of transgene expression with differentiation. Am. Soc. Gene Ther. 92a.
32. MILLER, A.D., and WOLGAMOT, G. (1997). Murine retroviruses use at least six different receptors for entry into Mus dunni cells. J. Virol. 71, 4531-4535.
33. MILLER, D.G., and MILLER, D. (1994). A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 68, 8270-8276.
34. NOLTA, J.A., HANLEY, M.B., and KOHN, D.B. (1994). Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors. Blood 83, 3041-3051.
35. PALMER, T.D., ROSMAN, G.J., OSBORNE, W.R., and MILLER, A.D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. U.S.A. 88, 1330-1334.
36. PEREIRA, R.F., HALFORD, K.W., O'HARA, M.D., LEEPER, D.B., SOKOLOV, B.P., POLLARD, M.D., BAGASRA, O., and PROCKOP, D.J. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. U.S.A. 92, 4857-4861.
37. PERSONS, D.A., ALLAY, J.A., ALLAY, E.R., SMEYNE, R.J., ASHMUN, R.A., SORRENTINO, B.P., and NIENHUIS, A.W. (1997). Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced protenitors in vitro and identification of genetically modified cells in vivo. Blood 90, 1777-1788.
38. PERSONS, D.A., MEHAFFEY, M.G., KALEKO, M., NIENHUIS, A.W., and VANIN, E.F. (1998). An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 15, 167-182.
39. PROCKOP, D.J. (1997). Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276, 71-74.
40. PROCKOP, D.J., HORWITZ, E.M., LAPTEV, A., PEREIRA, R., PHINNEY, D., and STOKES, D. (1998). Marrow stromal cells as stem cells for continual renewal of non-hematopoietic tissues and as potential vectors for gene therapy. In Hematopoietic Microenvironment. A. Keating and J.S. Greenberger, eds. (Cambridge, Cambridge University Press).
41. RICHARDSON, C., and BANK, A. (1996). Developmental stage-specific expression and regulation of an amphotropic retroviral receptor in hematopoietic cells. Mol. Cell. Biol. 16, 4240-4247.
42. RICKARD, D.J., SULLIVAN, T.A., SHENKER, B.J., LEBOY, P.S., and KAZHDAN, I. (1994). Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev. Biol. 161, 218-228.
43. ROBBINS, P.B., YU, X.-J., SKELTON, D.M., PEPPER, K.A., WASSERMAN, R.M., ZHU, L., and KOHN, D.B. (1997). Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J. Virol. 71, 9466-9474.
44. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd Ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
45. ST. LOUIS, D., and VERMA, I.M. (1988). An alternative approach to somatic cell gene therapy. Proc. Natl. Acad. Sci. U.S.A. 85, 3150-3154.
46. VALERA, A., PERALES, J.C., HATZOGLOU, M., and BOSCH, F. (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Ther. 5, 449-456.
47. VANIN, E.F., PERSONS, D.A., STEVENSON, S.C., FRARE, P., Mc-CLELLAN, A., and NIENHUIS, A.W. (1998). Adenoviral mediated expression of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector. Submitted for publication.
48. WINEMAN, J., MOORE, K., LEMISCHKA, I., and MULLER-SIEBURG, C. (1996). Functional heterogeneity of the hematopoietic microenvironment: Rare stromal elements maintain long-term repopulating stem cells. Blood 87, 4082-4090.